# Cyclobenzaprine hydrochloride

NDC: 0615-8508
Generic name: Cyclobenzaprine hydrochloride
Labeler / Manufacturer: NCS HealthCare of KY, LLC dba Vangard Labs
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET, FILM COATED
Routes: ORAL
Marketing started: 20200706

FDA application: ANDA213324

## Active ingredients

- CYCLOBENZAPRINE HYDROCHLORIDE: 5 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0615-8508"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0615-8508
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e332763b-00c6-41bf-84ae-a07d9ef79697